Mazumdar-Shaw: $100B of biologic drugs will lose patent protection by 2033
Kiran Mazumdar-Shaw · Ep #7 | Who is Kiran Mazumdar Shaw Really? And WTF is Biotech? · Nikhil Kamath · Jul 23, 2023 · at 1:44:21
Kiran Mazumdar-Shaw discusses the total addressable market and patent cliff for global biologics that Biocon Biologics is targeting.
0:00 / 0:09exact quote · 9.4s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“So I think there are about a hundred billion dollars of biologic drugs coming off patent in the next 10 years. And this is the opportunity we are addressing.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Kiran Mazumdar-Shaw
Mazumdar-Shaw: Vijay Mallya has paid back everything he owed
“Well, he's paid back everything he owed. So I don't understand why he's still being targeted.”
Mazumdar-Shaw: Biocon was the first startup in India
“Of course, a few years later, I was very lucky that I was able to get the brightest minds to join me, and I therefore consider myself really the first startup in the country.”
Mazumdar-Shaw: Entering biosimilars now would severely hurt Indian pharma earnings
“If any Indian pharmaceutical company wants to now venture into biosimilars, like I have done, it will, you know, have a huge impact on their EBITDA and their earnings, which I don't think anyone wants to do at this point in time.”
Mazumdar-Shaw: Regulations will permit CRISPR for genetic defects, not designer babies
“So I think they will allow you to use CRISPR technologies like they use gene therapies today. To basically correct genetic deficiencies, but not to choose the kind of baby you want, you know, like saying that, okay, I want my eyes, the eyes to be of this color…”
Mazumdar-Shaw: Going public creates valuation currency essential for scaling
“I believe that as you grow your company, you need you need a capital value for a kind of a currency that you use to grow your company with. So if you create a valuation for your company, you can use that as a very, very powerful currency to do many more things…”